Skip to main navigation Skip to search Skip to main content

Monthly: Y-mAbs Therapeutics (YMAB: $5.07) drops 17% on high volatility in August 2023

Press/Media: Research

PeriodSep 1 2023

Media coverage

1

Media coverage